2008
DOI: 10.1002/humu.20727
|View full text |Cite
|
Sign up to set email alerts
|

Homozygous mutation of the PHOX2B gene in congenital central hypoventilation syndrome (Ondine's Curse)

Abstract: Homozygosity for a dominant allele is relatively rare and preferentially observed in communities with high inbreeding. According to the definition of true dominance, similar phenotypes should be observed in patients heterozygous and homozygous for a dominant mutation. However, the homozygous phenotype usually tends to be more severe than the heterozygous one. In these cases, the wild-type and mutant alleles are semi-dominant. Here we report a patient with a Congenital Central Hypoventilation Syndrome (CCHS) ph… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
22
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 32 publications
(23 citation statements)
references
References 41 publications
(47 reference statements)
0
22
0
Order By: Relevance
“…While these individuals are often diagnosed in infancy and childhood, they can remain undiagnosed even to adulthood. In these individuals, discovery of hypoventilation may, at times, require an environmental cofactor such as sedation, anesthesia, anticonvulsants, severe respiratory illness, treated obstructive sleep apnea (Antic et al, 2006; Weese-Mayer et al, 2005) or the homozygous condition (Trochet et al, 2008) to elicit overt clinical events like hypoventilation and/or respiratory arrest. Thus far, fewer than 50 LO-CCHS cases have been reported, but considering the subtlety of the clinical profile in those cases, the prevalence in the general population is likely to be significantly higher than suggested by these few cases.…”
Section: Introductionmentioning
confidence: 99%
“…While these individuals are often diagnosed in infancy and childhood, they can remain undiagnosed even to adulthood. In these individuals, discovery of hypoventilation may, at times, require an environmental cofactor such as sedation, anesthesia, anticonvulsants, severe respiratory illness, treated obstructive sleep apnea (Antic et al, 2006; Weese-Mayer et al, 2005) or the homozygous condition (Trochet et al, 2008) to elicit overt clinical events like hypoventilation and/or respiratory arrest. Thus far, fewer than 50 LO-CCHS cases have been reported, but considering the subtlety of the clinical profile in those cases, the prevalence in the general population is likely to be significantly higher than suggested by these few cases.…”
Section: Introductionmentioning
confidence: 99%
“…However, array-CGH analysis revealed an interstitial microduplication of Xq28 encompassing the MECP2 gene, and further workup such as a search for Xq28 duplications is recommended for CCHS patients without PHOX2B or RET mutations [4]. The +4 alanine repeat mutation was previously identified in only two reports [15,16]. One described a CCHS patient harboring a homozygous mutation that was below the phenotypic threshold for dominant CCHS and that behaved as a recessive allele, while both heterozygous carrier parents were asymptomatic.…”
Section: Discussionmentioning
confidence: 93%
“…Contractions of the alanine tract by −3, −4, −5, −7, and −13 are rare variations in normal individuals but do not appear to cause CCHS [1,12,14]. The smallest polyalanine expansions were +4, and 20/25, 20/26, and 20/27 are the most common genotypes in CCHS patients [16,21].…”
Section: Discussionmentioning
confidence: 99%
“…The same 15-nucleotide deletion in the PHOX2B gene was discovered in normal Japanese individuals and also in patients with schizophrenia and exotropia [21]. In that study, it was concluded that the 15-nucleotide deletion was not associated with the development of exotropia in schizophrenic patients [21,22]. The 15-nucleotide deletion in PHOX2B results in the loss of 5 alanine residues in the alanine repeat of the protein, and the protein function remains at 60% of normal levels.…”
Section: Discussionmentioning
confidence: 93%